Advanced in Congenital Hyperinsulinism

Dr. Hala Tfayli

Pediatric Endocrinology | Pediatrics
Pittsburgh, PA 
Advanced in Congenital Hyperinsulinism
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Hala Tfayli is a Pediatric Endocrinologist and a Pediatrics provider in Pittsburgh, Pennsylvania. Dr. Tfayli is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Obesity in Children, Congenital Hyperinsulinism, Type 2 Diabetes (T2D), and Obesity.

Her clinical research consists of co-authoring 34 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 15 articles in the study of Congenital Hyperinsulinism.

Specialties
Pediatric Endocrinology
Pediatrics
Licenses
Pediatrics in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Pittsburgh, PA 15201

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-16)
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Heterozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-16)
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Drug: Inclisiran
Study Phase: Phase 3
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-13)
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-13)
Enrollment Status: Completed
Publish Date: May 31, 2025
Intervention Type: Drug
Study Drug: Inclisiran
Study Phase: Phase 3
View 1 Less Clinical Trial

34 Total Publications

FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature.
FBXO22 deficiency defines a pleiotropic syndrome of growth restriction and multi-system anomalies associated with a unique epigenetic signature.
Journal: American journal of human genetics
Published: October 08, 2024
Similar Doctors
Mary Vajravelu
Distinguished in Congenital Hyperinsulinism
Dr. Mary Vajravelu
Pediatric Endocrinology
Distinguished in Congenital Hyperinsulinism
Dr. Mary Vajravelu
Pediatric Endocrinology

Pediatric Endocrinology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.6 miles away)
412-692-5170
Languages Spoken:
English
See accepted insurances

Mary Vajravelu, MD, is certified in pediatrics and pediatric endocrinology by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Endocrinology and is affiliated with UPMC Children's Hospital of Pittsburgh. She completed her fellowship and residency at Children's Hospital of Philadelphia and medical degree at Case Western Reserve University School of Medicine. Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Vajravelu is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Congenital Hyperinsulinism, Newborn Low Blood Sugar, Obesity in Children, and Low Blood Sugar.

Radhika Muzumdar
Experienced in Congenital Hyperinsulinism
Dr. Radhika Muzumdar
Pediatric Endocrinology
Experienced in Congenital Hyperinsulinism
Dr. Radhika Muzumdar
Pediatric Endocrinology

Pediatric Endocrinology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.6 miles away)
412-692-5170
Languages Spoken:
English
See accepted insurances

Research Interests. Dr. Muzumdar is rated as an Advanced provider by MediFind in the treatment of Congenital Hyperinsulinism. Her top areas of expertise are Obesity, Nonalcoholic Steatohepatitis (NASH), Congenital Hypothyroidism, and Type 1 Diabetes (T1D).

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tfayli's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile